DSM is Awarded Membership in the PANOPTES EU Funded Consortium
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules.
RegeneRx's RGN-259 safe, well tolerated in patients with dry eye syndrome
RegeneRx Biopharmaceuticals, Inc. announced today that it has received the clinical study report for its recently completed Phase 2 clinical trial evaluating RGN-259 for the treatment of dry eye syndrome.
Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours
Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.
ECU scholarship honors Dr. Raniyah Ramadan
A scholarship honoring Dr. Raniyah Ramadan, a promising research scientist from Ada who passed away last July at age 34, has been established at East Central University.
Startup Wins $4 Million for Drug Delivery to the Eye
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.
Startup receives $4 million to develop drug delivery targeted to the back of the eye
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.
Award-winning physician appointed deputy director at NIMHD
The National Institute on Minority Health and Health Disparities (NIMHD) announced today the appointment of M. Roy Wilson, M.D., M.S., an award-winning physician and academic administrator, as NIMH's Deputy Director Strategic Scientific Planning and Program Coordination. NIMHD is part of the National Institutes of Health.
Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium’s goal is to research and develop novel drug delivery technology for ...
DOE may recommend reopening of FPIC pipeline
THE Department of Energy may endorse the reopening of First Philippine Industrial Corp.’s shuttered oil pipeline after initial tests point to the absence of leaks.
Press Release
Royal DSM N.V. Posted on:12 Jan 12 DSM , a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules.
|
